BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30477369)

  • 1. Utility of serum galactomannan antigen testing combined with chest computed tomography for early diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies with febrile neutropenia after antifungal drug treatment.
    Wang X; Guo G; Cai R; He P; Zhang M
    J Int Med Res; 2019 Feb; 47(2):783-790. PubMed ID: 30477369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia.
    Paholcsek M; Fidler G; Konya J; Rejto L; Mehes G; Bukta E; Loeffler J; Biro S
    BMC Infect Dis; 2015 Jul; 15():251. PubMed ID: 26126706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The early diagnostic value of serum galactomannan antigen test combined with chest computed tomography for invasive pulmonary aspergillosis in pediatric patients after hematopoietic stem cell transplantation.
    Qiu KY; Liao XY; Huang K; Xu HG; Li Y; Fang JP; Zhou DH
    Clin Transplant; 2019 Aug; 33(8):e13641. PubMed ID: 31211850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
    Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
    Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
    Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
    Tan BH; Low JG; Chlebicka NL; Kurup A; Cheah FK; Lin RT; Goh YT; Wong GC
    Int J Infect Dis; 2011 May; 15(5):e350-6. PubMed ID: 21397541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
    Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients.
    Couchepin J; Brunel AS; Jaton K; Meylan P; Bochud PY; Lamoth F
    Mycoses; 2018 Jun; 61(6):350-354. PubMed ID: 29453853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of peribronchial focal lesions of airway invasive aspergillosis in hematological cancer patients with prolonged neutropenia.
    Casutt A; Couchepin J; Brunel AS; Lovis A; Bochud PY; Keller N; Lamoth F; Beigelman-Aubry C
    Br J Radiol; 2020 Sep; 93(1113):20190693. PubMed ID: 32462888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.
    Hidalgo A; Parody R; Martino R; Sánchez F; Franquet T; Giménez A; Blancas C
    Eur J Radiol; 2009 Jul; 71(1):55-60. PubMed ID: 18468830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
    de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
    Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia.
    Demiraslan H; Atalay MA; Eren E; Demir K; Kaynar L; Koc AN; Doganay M
    Med Mycol; 2017 Jul; 55(5):535-540. PubMed ID: 27915301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience.
    Acet-Öztürk NA; Ömer-Topçu D; Vurat Acar K; Aydın-Güçlü Ö; Pınar İE; Demirdöğen E; Görek-Dilektaşlı A; Kazak E; Özkocaman V; Ursavas A; Özkalemkaş F; Ener B; Ali R; Akalın H
    Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):33-43. PubMed ID: 37910269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
    Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
    Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of broncho-alveolar lavage for galactomannan testing in hematological oncology patients.
    de Kruif MD; Gerritsen MG; van Haren EH; Bel EH; Jonkers RE
    Clin Respir J; 2017 Jul; 11(4):534-536. PubMed ID: 26364561
    [No Abstract]   [Full Text] [Related]  

  • 19. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.
    Hsu LY; Ding Y; Phua J; Koh LP; Chan DS; Khoo KL; Tambyah PA
    BMC Infect Dis; 2010 Mar; 10():44. PubMed ID: 20199673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum antigens assay combined with chest CT scan in diagnosis of invasive pulmonary aspergillosis].
    Xu PF; Zhou JY; Zhou H; Shen P
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 May; 41(3):332-8. PubMed ID: 22723171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.